About Joslin | Patient Care | Supporting Joslin
This study aims to collect high quality glycemic information from persons with type 1 diabetes using meal challenges.
Cross-sectional study assessing patient and parent preferences for an automated, on-body insulin delivery system, using semi-structured interviews and validated surveys in order to assist in the design of such a system.
This study is evaluating the accuracy of an investigational device (not FDA approved yet) called LabPatch Continuous Glucose Monitor by comparing it to a laboratory glucose analyser called YSI, and 2 commercial glucose meters.
A clinical trial to find out how well the continuous glucose monitor works in children less than 8 years old with T1D and whether an added program for parents/guardians can improve comfort with using the CGM and improve blood glucose control.
This study uses an electronic dose-recording device to examine dosing in individuals on multiple daily insulin injections.
This study assesses a new technology that aids the communication of health information amongst patients, family members/caregivers, and providers.
The study aims to identify youth and adults at risk for type 1 diabetes by testing for diabetes-related antibodies in relatives of people with type 1 diabetes.
The purpose of this
study is to study the development of the major long-term
complications of type 1 diabetes among the volunteers who participated in the
Diabetes Control and Complication Trial (DCCT) and the first twelve years of
the Epidemiology of Diabetes Interventions and Complications Study (EDIC).
This study is designed to test if the drug tocilizumab can help preserve or delay destruction of remaining beta cells in people recently diagnosed with type 1 diabetes.
This study will explore attitudes toward diabetes technology and automated insulin delivery.
We are looking for volunteers to help us find out more about usability of a proposed automated insulin delivery system named inControl.
The purpose of the "Monitoring Autoimmunity in Diabetes" study is to look at changes in the body that may occur with the development of type 1 diabetes.
The purpose of this study
is to document the presence of eye, nerve and kidney complications related to
diabetes, as well as to examine DNA and substances in the blood and urine of
people with diabetes for 50 years or more.
purpose of this study is to find out whether a medication called allopurinol
can prevent kidney problems, in particular the loss of kidney function, in
people with type 1 diabetes.
This study aims to determine if the drug SIMPONI® (golimumab) can preserve beta-cell function in children and young adults with newly diagnosed type 1 diabetes.
This study aims to assess if one's own expanded regulatory T cells can rebalance the immune system, decreasing the attack on the insulin producing cells in type 1 diabetes.